ACHV
Achieve Life Sciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.17
+0.03 ▲ +0.72%
🌙 3월 13일 7:43 PM ET (한국 3/14 08:43)
$4.20
+0.03 ▲ +0.72%
| Index | - | P/E | - | EPS (ttm) | -1.38 | Insider Own | 12.49% | Shs Outstand | 0.05B | Perf Week | -2.34% |
| Market Cap | 0.22B | Forward P/E | - | EPS next Y | 2.35% | Insider Trans | -2.63% | Shs Float | 0.05B | Perf Month | -2.57% |
| Enterprise Value | 0.18B | PEG | - | EPS next Q | -0.29 | Inst Own | 46.18% | Short Float | 14.44% | Perf Quarter | -9.54% |
| Income | -0.05B | P/S | - | EPS this Y | -2.9% | Inst Trans | 7.36% | Short Ratio | 11.39 | Perf Half Y | 31.96% |
| Sales | 0.00B | P/B | 6.55 | EPS next 5Y | 46.02% | ROA | -104.74% | Short Interest | 6.73M | Perf YTD | -16.1% |
| Book/sh | 0.64 | P/C | 4.61 | EPS past 3/5Y | 32.75% 50.01% | ROE | -161.08% | 52W High | -30.79% ($6.03) | Perf Year | 57.36% |
| Cash/sh | 0.9 | P/FCF | - | Sales past 3/5Y | - | ROIC | -123.72% | 52W Low | 126.63% ($1.84) | Perf 3Y | -2.57% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -22.06% | Gross Margin | - | Volatility(W/M) | 5.01% 5.48% | Perf 5Y | -64.21% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.25 | Perf 10Y | -99.77% |
| Dividend Ex-Date | - | Quick Ratio | 5.14 | EPS Q/Q | 22.27% | Profit Margin | - | RSI (14) | 43.36 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.14 | Sales Q/Q | - | SMA20 | -4.34% ($4.36) | Beta | 1.84 | Target Price | $14 |
| Payout | - | Debt/Eq | 0.3 | Earnings | 11000000 | SMA50 | -11.03% ($4.69) | Rel Volume | 0.61 | Prev Close | $4.14 |
| Employees | 25 | LT Debt/Eq | 0.26 | EPS/Sales Surpr. | -14.75% - | SMA200 | 9.3% ($3.82) | Avg Volume(3M) | 0.59M | Price | $4.17 |
| IPO | 1995/10/12 | Option/Short | Yes/Yes | Trades | 2899 | Volume | 362,233 | Change | 0.72% |
뉴스 로딩 중...